IS1901B - Efnasambönd til að hindra magasýruseytrun - Google Patents

Efnasambönd til að hindra magasýruseytrun

Info

Publication number
IS1901B
IS1901B IS5148A IS5148A IS1901B IS 1901 B IS1901 B IS 1901B IS 5148 A IS5148 A IS 5148A IS 5148 A IS5148 A IS 5148A IS 1901 B IS1901 B IS 1901B
Authority
IS
Iceland
Prior art keywords
compounds
gastric acid
acid secretion
inhibit gastric
inhibit
Prior art date
Application number
IS5148A
Other languages
English (en)
Icelandic (is)
Other versions
IS5148A (is
Inventor
Amin Kosrat
Dahlström Mikael
Nordberg Peter
Starke Ingemar
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS5148A publication Critical patent/IS5148A/is
Publication of IS1901B publication Critical patent/IS1901B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5148A 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun IS1901B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (2)

Publication Number Publication Date
IS5148A IS5148A (is) 1999-08-05
IS1901B true IS1901B (is) 2003-11-20

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5148A IS1901B (is) 1997-02-25 1999-08-05 Efnasambönd til að hindra magasýruseytrun

Country Status (32)

Country Link
US (1) US6265415B1 (enExample)
EP (1) EP0971920B1 (enExample)
JP (1) JP2001512477A (enExample)
KR (1) KR20000075622A (enExample)
CN (1) CN1100056C (enExample)
AR (1) AR011134A1 (enExample)
AT (1) ATE218569T1 (enExample)
AU (1) AU723389B2 (enExample)
BR (1) BR9807457A (enExample)
CA (1) CA2280008A1 (enExample)
CZ (1) CZ291681B6 (enExample)
DE (1) DE69805787T2 (enExample)
DK (1) DK0971920T3 (enExample)
EE (1) EE04016B1 (enExample)
ES (1) ES2178169T3 (enExample)
HU (1) HUP0000720A3 (enExample)
ID (1) ID22218A (enExample)
IL (1) IL131122A0 (enExample)
IS (1) IS1901B (enExample)
MY (1) MY118822A (enExample)
NO (1) NO313009B1 (enExample)
NZ (1) NZ336878A (enExample)
PL (1) PL190379B1 (enExample)
PT (1) PT971920E (enExample)
RU (1) RU2193036C2 (enExample)
SE (1) SE9700661D0 (enExample)
SK (1) SK283903B6 (enExample)
TR (1) TR199902060T2 (enExample)
TW (1) TW568907B (enExample)
UA (1) UA64741C2 (enExample)
WO (1) WO1998037080A1 (enExample)
ZA (1) ZA981134B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
EP0909323B1 (en) * 1996-01-04 2007-02-28 Novartis Vaccines and Diagnostics, Inc. Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
WO2004026867A2 (en) 2002-09-19 2004-04-01 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
PT2476667E (pt) * 2003-02-26 2014-09-18 Sugen Inc Compostos de aminoheteroarilo como inibidores da proteína quinase
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
JP4977465B2 (ja) * 2004-07-28 2012-07-18 武田薬品工業株式会社 ピロロ[2,3−c]ピリジン化合物、その製造方法および用途
ES2426920T3 (es) 2004-09-03 2013-10-25 Yuhan Corporation Derivados de pirrolo[3,2-B]piridina y procesos para su preparación
DK1784402T3 (da) 2004-09-03 2011-11-14 Yuhan Corp Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-a]피리딘 유도체 및 그의 제조방법
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
JP2008536817A (ja) * 2005-03-24 2008-09-11 グラクソ グループ リミテッド 胃腸疾患の処置用医薬として有用なイミダゾ(1,2−a)ピリジン誘導体
PT1963302E (pt) 2005-12-05 2013-04-09 Pfizer Prod Inc Polimorfos de um inibidor de c-met/hgfr
DE602006018354D1 (de) 2005-12-05 2010-12-30 Pfizer Prod Inc Verfahren zur behandlung von abnormalem zellwachstum
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
IN2012DN04917A (enExample) * 2009-11-05 2015-09-25 Univ Notre Dame Du Lac
EP2716642B1 (en) 2011-05-30 2016-07-20 Astellas Pharma Inc. Imidazopyridine compound
EP2927231B1 (en) * 2012-11-30 2017-09-20 Astellas Pharma Inc. Imidazopyridine compounds
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
CA2280008A1 (en) 1998-08-27
CZ301499A3 (cs) 2000-02-16
RU2193036C2 (ru) 2002-11-20
DK0971920T3 (da) 2002-09-16
CN1100056C (zh) 2003-01-29
PL335485A1 (en) 2000-04-25
KR20000075622A (ko) 2000-12-26
IS5148A (is) 1999-08-05
CZ291681B6 (cs) 2003-04-16
EE9900367A (et) 2000-04-17
AR011134A1 (es) 2000-08-02
DE69805787T2 (de) 2003-01-02
ID22218A (id) 1999-09-16
WO1998037080A1 (en) 1998-08-27
SE9700661D0 (sv) 1997-02-25
IL131122A0 (en) 2001-01-28
UA64741C2 (uk) 2004-03-15
DE69805787D1 (de) 2002-07-11
ZA981134B (en) 1998-08-25
HUP0000720A2 (hu) 2000-10-28
ATE218569T1 (de) 2002-06-15
PT971920E (pt) 2002-11-29
SK109999A3 (en) 2000-01-18
ES2178169T3 (es) 2002-12-16
US6265415B1 (en) 2001-07-24
JP2001512477A (ja) 2001-08-21
MY118822A (en) 2005-01-31
BR9807457A (pt) 2000-04-25
CN1248257A (zh) 2000-03-22
NO994078D0 (no) 1999-08-24
AU6314798A (en) 1998-09-09
PL190379B1 (pl) 2005-12-30
TR199902060T2 (xx) 2000-02-21
SK283903B6 (sk) 2004-04-06
NO313009B1 (no) 2002-07-29
HK1024248A1 (en) 2000-10-05
NZ336878A (en) 2001-05-25
EP0971920B1 (en) 2002-06-05
MX9907650A (es) 2002-12-13
AU723389B2 (en) 2000-08-24
EP0971920A1 (en) 2000-01-19
TW568907B (en) 2004-01-01
NO994078L (no) 1999-08-24
HUP0000720A3 (en) 2001-01-29
EE04016B1 (et) 2003-04-15

Similar Documents

Publication Publication Date Title
IS5148A (is) Efnasambönd til að hindra magasýruseytrun
DE69918278D1 (de) Substituierte indolalkansäure
ID20809A (id) Asam diaminokarboksilat tersubstitusi
DE69907435D1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
ID24314A (id) Tempat umpan bersekat-sekat
ID20807A (id) Asam sulfonilaminokarboksilat
DE69828371D1 (de) Wasserdichter Verbinder
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
DK0944386T3 (da) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyclylamid-forbindelser
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
NO991561L (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
DE69838190D1 (de) Wasserdichter Verbinder
NO306159B1 (no) 5-arylisoksazol-4-substituerte 2-aminokarboksylsyreforbindelser
ID24327A (id) Produksi senyawa-senyawa avermektin
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
FI973826L (fi) Suoritettavat ohjelmat
FI972410A7 (fi) Mahahapon eritystä ehkäisevät yhdisteet
DE69311355D1 (de) Persäure-verbindungen
IT242664Y1 (it) Sovrascarpe impermeabili
SE9702775D0 (sv) Novel compounds
KR960011313U (ko) 방수용 벽돌
NO974296D0 (no) Aminosyreforbindelse
SI0971920T1 (en) Compounds for inhibition of gastric acid secretion
SE9701099D0 (sv) Novel compounds
SE9702198D0 (sv) Novel compounds